Reviews in Gynaecological Practice最新文献_第7页

Health consequences of female genital mutilation 切割女性生殖器官对健康的影响

Reviews in Gynaecological Practice Pub Date : 2004-12-01 DOI: 10.1016/j.rigp.2004.06.001

Marcel Reyners

{"title":"Health consequences of female genital mutilation","authors":"Marcel Reyners","doi":"10.1016/j.rigp.2004.06.001","DOIUrl":"10.1016/j.rigp.2004.06.001","url":null,"abstract":"<div><p>The practice of female genital mutilation (FGM) is no longer confined to African countries where still every year 2 million girls at a young age are currently subjected to surgical ablation of parts of their external genital organs. Health professionals in Western countries, especially midwives and gynaecologists, are regularly confronted not only with the sequelae of excision and infibulation but also with parents’ requests to perform FGM or to repair a widened introı̈tus. The international community condemns firmly every attempt to continue this practice whether the original one in societies promoting FGM or a minor variety to be performed under medical conditions in order to prevent worse, as sometimes recommended by compassionate or tolerant people in Western countries or asked in Africa by educated parents or by immigrant parents in Europe and America. Consequences of FGM are medical, psychological and psycho-sexual as well. General practitioners, midwives and gynaecologists should be aware of this condition and most of all of the infibulation type as it might heavily affect reproductive and urological functioning of girls and women. Women original from areas where FGM is endemic should be extensively counseled, carefully examined and closely followed up, especially during pregnancy. A detailed plan of action should be established for pregnancy, delivery and post-partum period. Detailed information and appropriate illustrations are provided on defibulation techniques and procedures during delivery. The medical profession can play an important role in raising awareness about the harmful consequences of FGM and in preventing its application.</p></div>","PeriodicalId":101089,"journal":{"name":"Reviews in Gynaecological Practice","volume":"4 4","pages":"Pages 242-251"},"PeriodicalIF":0.0,"publicationDate":"2004-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rigp.2004.06.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75445070","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 36

History of assisted reproduction: lessons learnt and future challenges 辅助生殖的历史:经验教训和未来的挑战

Reviews in Gynaecological Practice Pub Date : 2004-12-01 DOI: 10.1016/j.rigp.2004.04.003

Eduardo Pandolfi Passos

引用次数: 6

Subject Index of Volume 4 第四卷主题索引

Reviews in Gynaecological Practice Pub Date : 2004-12-01 DOI: 10.1016/S1471-7697(04)00110-8

引用次数: 0

The development of recombinant follicle stimulating hormone (rFSH) for use in the treatment of infertility: new solutions to old challenges 用于治疗不孕症的重组促卵泡激素(rFSH)的开发:新解决方案的老挑战

Reviews in Gynaecological Practice Pub Date : 2004-12-01 DOI: 10.1016/j.rigp.2004.06.003

Wendy D. Latash, Vishvanath C. Karande, Sigal Klipstein

{"title":"The development of recombinant follicle stimulating hormone (rFSH) for use in the treatment of infertility: new solutions to old challenges","authors":"Wendy D. Latash, Vishvanath C. Karande, Sigal Klipstein","doi":"10.1016/j.rigp.2004.06.003","DOIUrl":"10.1016/j.rigp.2004.06.003","url":null,"abstract":"<div><p>Recombinant follicle stimulating hormone (rFSH) has been in use in the management of infertility for the past decade. It is a virtually pure compound, with excellent batch-to-batch consistency and the ability to be produced in almost limitless quantities. A historical perspective leading to the development of recombinant products will be discussed, including a review of the two-cell, two-gonadotrophin theory of folliculogenesis. The two currently available recombinant follicle stimulating hormones (follitropin α and follitropin β) will be compared with each other and with urinary follicle stimulating hormone (uFSH) preparations. This comparison will highlight their safety, efficacy and side effect profiles. The use of recombinant follicle stimulating hormone in the special cases of polycystic ovarian syndrome and hypothalamic amenorrhea will be detailed. Finally, future directions in recombinant therapy will be considered, including the creation of long-acting preparations, the development of recombinant luteinizing hormone, and the potential future availability of more convenient administration systems.</p></div>","PeriodicalId":101089,"journal":{"name":"Reviews in Gynaecological Practice","volume":"4 4","pages":"Pages 203-210"},"PeriodicalIF":0.0,"publicationDate":"2004-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rigp.2004.06.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88142185","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

Can we eliminate severe ovarian hyperstimulation syndrome? 我们能消除严重卵巢过度刺激综合征吗?

Reviews in Gynaecological Practice Pub Date : 2004-12-01 DOI: 10.1016/j.rigp.2004.06.002

Raoul Orvieto

引用次数: 0

How widespread are STDs?: Need for improvement in surveillance systems, interpretation of test results and screening programs, as exemplified by genital chlamydial infection 性传播疾病有多普遍?需要改进监测系统、检测结果的解释和筛查规划，例如生殖器衣原体感染

Reviews in Gynaecological Practice Pub Date : 2004-09-01 DOI: 10.1016/J.RIGP.2004.01.005

P. Mårdh

引用次数: 7

How widespread are STDs? 性传播疾病有多普遍?

Reviews in Gynaecological Practice Pub Date : 2004-09-01 DOI: 10.1016/j.rigp.2004.01.005

Per-Anders Mårdh

引用次数: 7

Saline infusion sonohysterography (SIS) 生理盐水输注超声宫腔镜(SIS)

Reviews in Gynaecological Practice Pub Date : 2004-09-01 DOI: 10.1016/j.rigp.2004.04.001

Gautam N Allahbadia , Kaushal Kadam , Swati Allahbadia

引用次数: 10

Editors 编辑器

Reviews in Gynaecological Practice Pub Date : 2004-09-01 DOI: 10.1016/S1471-7697(04)00077-2

引用次数: 0

Current developments in vaginal hormonal contraception 阴道激素避孕的最新进展

Reviews in Gynaecological Practice Pub Date : 2004-09-01 DOI: 10.1016/j.rigp.2004.02.003

Daniel S. Seidman

{"title":"Current developments in vaginal hormonal contraception","authors":"Daniel S. Seidman","doi":"10.1016/j.rigp.2004.02.003","DOIUrl":"10.1016/j.rigp.2004.02.003","url":null,"abstract":"<div><p>A novel combined hormonal vaginal contraceptive ring (VCR) is currently commercially marketed (<em>NuvaRing</em><sup>®</sup>, NV Organon, Oss, The Netherlands). This VCR continuously releases 15μg of ethinyl estradiol and 120<!--> <span>μg of etonogestrel, the active metabolite of the progestin desogestrel. The VCR is soft and flexible, with an outer diameter of 54 mm and a cross section of 4</span> <span>mm. Each VCR is intended for one monthly cycle, comprising 3 weeks of ring use and 1 week ring-free period. The VCR is easily inserted at a woman’s discretion. Due to the controlled release mechanism of the contraceptive ring, steroid concentrations remain uniform throughout the cycle. Large mulicenter studies of the VCR have revealed a high contraceptive efficacy, with a Pearl Index of 0.65 and 1.18. Cycle control is excellent with irregular bleeding reported in about 5% or less of all cycles with the VCR. The most frequently reported adverse events are device-related events (e.g. foreign body sensation, coital problems and device expulsion), vaginal discomfort, headache, vaginitis and leucorrhea. The overall acceptance of the VCR is high, as 96% of patients are satisfied with the ring and 97% would recommend the ring. The VCR represents an important new option for women desiring highly effective contraception. The ease of use and exceptional cycle control all lead to high patient compliance with the VCR.</span></p></div>","PeriodicalId":101089,"journal":{"name":"Reviews in Gynaecological Practice","volume":"4 3","pages":"Pages 169-174"},"PeriodicalIF":0.0,"publicationDate":"2004-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rigp.2004.02.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77826115","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1